Crystal form A of a compound represented by formula (I) and an application thereof in preparing a drug for treating an SGLT1/SGLT2-related disease.

##STR00001##

Provided herein are efficient and scalable methods for the synthesis of nicotinamide riboside from riboside triacetate. Also provided are compositions comprising nicotinamide riboside, and therapeutic methods employing nicotinamide riboside.

Provided herein are efficient and scalable methods for the synthesis of nicotinamide riboside from riboside triacetate. Also provided are compositions comprising nicotinamide riboside, and therapeutic methods employing nicotinamide riboside.

The invention relates to a process for the preparation of a solid allulose material comprising crystalline allulose, the method comprising the steps of (a) providing in an evaporating crystallizer an aqueous mother liquor containing dissolved allulose; (b) maintaining, preferably until the end of crystallization, the aqueous mother liquor within the evaporating crystallizer at a crystallization temperature within the range of from 20 to 80° C.; (c) maintaining, preferably until the end of crystallization, the vapor phase above the aqueous mother liquor within the evaporating crystallizer at a crystallization pressure within the range of from 40 to 500 mbar; and (d) inducing crystallization of allulose from the aqueous mother liquor at the crystallization temperature and at the crystallization pressure in a supersaturated state thereby obtaining the solid allulose material as a precipitate and a supernatant.

The invention relates to a process for the preparation of a solid allulose material comprising crystalline allulose, the method comprising the steps of (a) providing in an evaporating crystallizer an aqueous mother liquor containing dissolved allulose; (b) maintaining, preferably until the end of crystallization, the aqueous mother liquor within the evaporating crystallizer at a crystallization temperature within the range of from 20 to 80° C.; (c) maintaining, preferably until the end of crystallization, the vapor phase above the aqueous mother liquor within the evaporating crystallizer at a crystallization pressure within the range of from 40 to 500 mbar; and (d) inducing crystallization of allulose from the aqueous mother liquor at the crystallization temperature and at the crystallization pressure in a supersaturated state thereby obtaining the solid allulose material as a precipitate and a supernatant.

Methods of preparing novel steviol glycosides are described herein. The methods utilize biocatalysts for converting a starting steviol glycoside to a target steviol glycoside. Compositions and consumables comprising said novel steviol glycosides as well as methods of purifying and using said novel steviol glycosides, are also provided.

Methods of preparing highly purified steviol glycosides, particularly rebaudiosides A, D and M are described. The methods include utilizing recombinant microorganisms for converting various staring compositions to target steviol glycosides. In addition, novel steviol glycosides reb D2, reb M2, and reb I are disclosed, as are methods of preparing the same. The highly purified rebaudiosides are useful as non-caloric sweetener in edible and chewable compositions such as any beverages, confectioneries, bakery products, cookies, and chewing gums.

Methods of preparing highly purified steviol glycosides, particularly rebaudiosides A, D and M are described. The methods include utilizing recombinant microorganisms for converting various staring compositions to target steviol glycosides. In addition, novel steviol glycosides reb D2, reb M2, and reb I are disclosed, as are methods of preparing the same. The highly purified rebaudiosides are useful as non-caloric sweetener in edible and chewable compositions such as any beverages, confectioneries, bakery products, cookies, and chewing gums.

The invention relates to a method for selective crystallization of 2′-FL from an aqueous solution comprising 2′-FL and one or more other fucosylated carbohydrates by adding acetic acid to the solution.

The invention relates to a method for selective crystallization of 2′-FL from an aqueous solution comprising 2′-FL and one or more other fucosylated carbohydrates by adding acetic acid to the solution.